Pliant Therapeutics Announces 4 Upcoming Presentations At The ERS International Congress 2024
Author: Benzinga Newsdesk | August 26, 2024 09:11am
Pliant Therapeutics, Inc. (NASDAQ:PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced four upcoming presentations at the European Respiratory Society (ERS) International Congress 2024. The Congress will take place in Vienna, Austria from September 7 - 11, 2024.
Posted In: PLRX